Margaret Foti to be honored for significant contributions to cancer care

June 03, 2004

Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the American Association for Cancer Research, is the recipient of the American Society of Clinical Oncology's 2004 Special Recognition Award, given annually to acknowledge individuals who have had a major impact in areas of clinical oncology, cancer research, clinical trials, reimbursement and patient advocacy activities, as well as outstanding, long-term service to ASCO and to clinical oncology.

The award will be presented June 5 at the Inaugural Session of the society's 40th Annual Meeting at the Ernest N. Morial Convention Center in New Orleans.

The ASCO Special Recognition Award winner is chosen by a selection committee, chaired this year by Immediate Past President Paul A. Bunn, Jr., M.D., who is a professor and director of the University of Colorado Cancer Center in Denver, and also a long-time member of the AACR.

In choosing Foti for the honor, the committee cited, "her instrumental role in the development of the AACR/ ASCO Joint Workshop, 'Methods in Clinical Cancer Research,' which has served as the prototype for subsequent workshops designed to introduce beginning oncologists in Europe and Australia to the essentials of effective clinical trials design." They noted also Foti's efforts "to provide vital links between translational scientists and clinicians," and her fostering of "important connections between these two research groups."

"I am deeply honored to receive this award, which is all the more meaningful coming from ASCO," Foti said. "ASCO is one of our most valued and long-term collaborators in strengthening cancer education and communication. Our close relationship has become increasingly important in this modern era of translational cancer research and synergistic targeted therapies," she added.

A native of Philadelphia, Foti has dedicated virtually her entire professional career to the AACR, first as an editorial assistant for the association's flagship journal, Cancer Research - which she continues to serve as managing editor. She became executive director in 1982 and chief executive officer in 2000. She is a graduate of Temple University and its School of Communications and Theater, where she earned her master's and doctoral degrees.

In 2003, Foti received the Doctor of Medicine and Surgery Honoris Causa from the University of Rome; she lectured there and at the University of Palermo on the topic of "The Vital Role of Research in the Conquest of Cancer: Progress and Promise in the New Era of Science."

Also, last year, she was honored by the William S. Graham Foundation for Melanoma Research, known popularly as "The Billy Foundation," with its annual CommunityCaring Award. She is the recipient as well of the Cino del Duca Oncology Award for "outstanding work in raising public consciousness in the support of cancer research, treatment, and prevention," the Ville de Paris Award for her contributions to the field of cancer, and several awards from the AACR for advancing progress against cancer.

Previous recipients of the ASCO Special Recognition Award include Nancy Brinker, founder of the Susan G. Komen Breast Cancer Foundation; Ellen Sigal, president of the Friends of Cancer Research; Don Shula, whose foundation is dedicated to breast cancer research; retired Army Gen. Norman Schwartzkopf; and renowned cancer physicians Kathleen Foley, John Durant and Harold Freeman.
-end-
Founded in 1907, the American Association for Cancer Research is a professional society of more than 22,000 laboratory, translational, and clinical scientists engaged in all areas of cancer research in the United States and in more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication, and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. AACR's Annual Meeting attracts more than 15,000 participants who share new and significant discoveries in the cancer field. Specialty meetings, held throughout the year, focus on the latest developments in all areas of cancer research.

American Association for Cancer Research

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.